Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2099-2109
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2099
Table 1 Clinicopathological characteristics based on methylated septin 9 status in 300 colorectal cancer patients
ParameterPositive group (%)Negative group (%)P
GenderMale84 (28.0)81 (27.0)0.585
Female73 (24.3)62 (20.7)
Age≤ 50 yr45 (15.0)60 (20.0)0.016
> 50 yr112 (37.3)83 (27.7)
UICC stageI9 (3.0)20 (6.7)0.020
II46 (15.3)32 (10.7)
III62 (20.6)71 (23.7)
IV13 (4.3)6 (2.0)
Unknown27 (9.0)14 (4.7)
Histologic gradeLow level115 (38.3)103 (34.3)0.972
High level18 (6.0)17 (5.7)
Not recorded24 (8.0)23 (7.7)
Primary tumor (T) categoryT12 (0. 7)3 (1.0)0.002
T215 (5.0)23 (7.7)
T370 (23.3)67 (22.3)
T440 (13.3)34 (11.3)
Not recorded30 (10.0)16 (5.3)
Regional node (N) categoryN057 (19.0)23 (7.7)0.852
N132 (10.7)67 (22.3)
N237 (12.3)34 (11.3)
Not recorded31 (10.3)16 (5.3)
Distant metastasis (M)Absent141 (47.0)137 (45.7)0.015
Present16 (5.3)6 (2.0)
Lymphatic invasion (L)Absent58 (19.3)60 (20.0)0.217
Present51 (17.0)52 (17.3)
Not recorded48 (16.0)31 (10.3)
Lymph nodal statusNo node involved51 (17.0)52 (17.3)0.048
1-3 lymph node involved27 (9.0)40 (13.3)
> 4 lymph node involved31 (10.3)20 (6.7)
Not recorded48 (16)31 (10.3)
Vascular invasion (V)Absent36 (12.0)31 (10.3)0.278
Present70 (23.3)76 (25.3)
Not recorded51 (17.0)36 (12.0)
Tumor siteaLeft colon44 (14.7)31 (10.3)0.022
Right colon27 (9.0)11 (3.7)
Rectum74 (24.7)86 (28.6)
Unable to distinguish12 (4.0)15 (5.0)